GNTA: SEC Form 6-K filed by Genenta Science S.p.A.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for GNTA
Across the 14 sessions after earlier GNTA headlines, the stock closed higher 7 times and lower 7 times, with a median move of 2.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GNTA | SPY |
|---|---|---|---|
| Oct 22, 2026 | Genenta Science Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification | -1.5% | -1.2% |
| Sep 15, 2026 | Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit | -0.2% | -0.5% |
| Jul 23, 2026 | Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm | +0.6% | -1.2% |
| Jul 22, 2026 | Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results | -0.6% | -0.1% |
| Apr 23, 2026 | Genenta signs Definitive Agreements with Sophia High Tech | -1.7% | -0.4% |
| Mar 27, 2026 | Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs | -14.3% | -1.7% |
Quantisnow market dataNASDAQ
GNTA
Genenta Science S.p.A.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for GNTA
Full GNTA profile on Quantisnow Follow GNTA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time